Menu

Ranolazine ER

Strength: 1000mg Count: 30

NDC

50268-723-13

Class

Rx

Brand Name

Ranexa Extended-Release

Imprint Code

A48;1000

Color(s)

Yellow

Shape

Oval (oval shaped biconvex)

Score

No Score

Case Count

NA

Inactive Ingredients

colloidal silicon dioxide, hypromellose, iron oxide yellow, magnesium stearate, methacrylic acid copolymer, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium hydroxide, talc, titanium dioxide

Indications and Usage

Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti- platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers